Recalls & Warnings
ConsumerLab.com is keeping you informed with current product recalls and warnings.
Latest Posted March 30, 2023
Seller of Tollovid Supplements Warned for COVID-19 Claims
On November 7, 2022, the FDA issued a warning letter to Todos Medical Ltd, aka Todos Medical USA Inc, following a review of the company’s websites, social media, and Amazon storefronts, which found statements about the company’s Tollovid 3CL Protease Inhibitor Delayed Release (Tollovid) supplements to be drug claims.
Tollovid was sold on Amazon, and promoted on the company’s social media and other websites. According the Todos’ website, its Tollovid supplement contains gromwell root, soy lecithin, powdered cellulose, HPMC capsule, silicon dioxide, magnesium stearate, and titanium dioxide.
The FDA’s warning letter states that the company promoted its Tollovid supplements to prevent or treat COVID-19 with statements such as, “3CL Protease Inhibitors: The Potential Key to Combating the SARS-CoV-2 Virus Life Cycle . . . Studies have shown … that by using protease inhibitors, we can stop the virus’ ability to replicate itself, halting the spread in it [sic] tracks.” and with testimonials such as, “My family and I were directly exposed a few weeks ago, we had just started taking Tollovid and no one in my family contracted it while the other family we were with all ended up positive and sick. While there is no way of proving it was because of taking Tollovid, I’m grateful we were on it and will continue to take it.”
Todos Medical USA Inc must respond to the FDA within 48 hours describing the specific steps it has taken to correct these violations.
For more information about related products, see ConsumerLab’s answer the question: Do any supplements help with the coronavirus (COVID-19)? Do supplements like vitamin D, zinc, vitamin C, or herbals work?
For more information, use the link below.
Warning: Todos Medical Ltd aka Todos Medical USA Inc
See related recalls and warnings:
Seller of CBD Warned for COVID-19 Claims
FDA Warns Companies Promoting Products to Treat Monkeypox, COVID-19, & Other Viruses
Natural Solutions Foundation Banned From Selling "Nano Silver" as COVID Treatment
DoTerra Sellers Ordered to Pay $15,000 for Deceptive COVID-19 Claims
FTC Takes Action Against Company Promoting “COVID Resist” Supplement to Treat COVID-19
For information about reporting serious reactions and problems with medical products to the U.S. Food and Drug Administration through its MedWatch reporting program, please visit the FDA MedWatch website.